Gene · 3039
NIH grants1,435
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,435
Download this page as JSON| Grant | Title | HBA1 papers | Newest fiscal year |
|---|---|---|---|
| K01MH125144 | Mechanisms regulating neural stem cell maintenance in the dentate gyrus | 1 | 2024 |
| K02NS112600 | Joint analysis of genomic and electronic medical record data to assess outcomes and drug response in pediatric epilepsies | 1 | 2024 |
| K08AG065502 | Genome-Wide Somatic Mutation in Alzheimer's Disease Pathogenesis Using Single Neuron Analysis | 1 | 2024 |
| K08CA245209 | Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia | 1 | 2024 |
| K23HL146904 | Kinetics of Red Blood Cell Clearance in Chronically Transfused Children with Sickle Cell Disease | 1 | 2024 |
| K25HL150334 | Exploring the role of genomic repeats in cardiovascular disease heritability | 1 | 2024 |
| K99HL156060 | NET stabilization: mechanistic and therapeutic studies in thromboinflammatory disoders | 1 | 2024 |
| P01AG025204 | The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease | 1 | 2024 |
| P01AG060882 | Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease | 1 | 2024 |
| P01CA093900 | The Biology of Prostate Cancer Skeletal Metastases | 1 | 2024 |
| P20GM109005 | Center for Studies of Host Response to Cancer Therapy | 1 | 2024 |
| P30AG038072 | Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging | 1 | 2024 |
| P30EY002687 | Core Grant for Vision Research | 1 | 2024 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 1 | 2024 |
| P50CA098131 | SPORE in Breast Cancer | 1 | 2024 |
| R01AG015819 | Risk Factors, Pathology, and Clinical Expressions of AD | 1 | 2024 |
| R01AI114362 | Transcriptional regulatory mechanisms shaping HIV proviral fate | 1 | 2024 |
| R01AI114523 | Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome | 1 | 2024 |
| R01CA030488 | Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines | 1 | 2024 |
| R01CA189806 | Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/grants?page=16